Transcatheter aortic valve ‐in‐valve treatment of degenerative stentless supra‐annular Freedom Solo valves: A single centre experience

ConclusionsViV‐TAVI in stentless Freedom Solo valves is high risk. The risk of coronary occlusion is high. The smallest possible prosthesis (1:1 sizing) should be used, and strategies to protect the coronary vessels must be considered. © 2016 Wiley Periodicals, Inc.

Source: Catheterization and Cardiovascular Interventions - June 16, 2016 Category: Cardiovascular & Thoracic Surgery Authors: James Cockburn, Maureen Dooley, Jessica Parker, Andrew Hill, Nevil Hutchinson, Adam de Belder, Uday Trivedi, David Hildick ‐Smith Tags: Valvular and Structural Heart Diseases Source Type: research